Merck extends Vioxx settlement deadline
Executive Summary
Merck is extending to June 30 the deadline for eligible claimants to enroll in the Vioxx settlement agreement. Under the agreement, Merck agreed to pay a fixed amount of $4.85 billion to cover 45,000 to 50,000 heart attack and stroke claims (1"The Pink Sheet," Nov. 12, 2007, p. 11). The deal is contingent on participation of 85 percent of all plaintiffs with pending and tolled claims against the company. Merck said that as of March 31, it appears that at least 94.5 percent of eligible claims in each category had initiated enrollment
You may also be interested in...
Merck’s Novel Vioxx Settlement May Set Standard To Resolve Litigation
Merck crafted extraordinary terms in its $4.85 billion agreement to resolve the bulk of Vioxx litigation, which analysts are heralding as a good result for the company
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.